Stay updated on Immunotherapy Combination in Solid Cancers Clinical Trial
Sign up to get notified when there's something new on the Immunotherapy Combination in Solid Cancers Clinical Trial page.

Latest updates to the Immunotherapy Combination in Solid Cancers Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedResults data were added to the study record with Results First Submitted on 2025-08-08 and Results First Posted on 2025-08-29, and the Outcome Measures section was expanded to include adverse events, objective response rate, duration of response, progression-free survival, and PK/PD parameters.SummaryDifference0.3%

- Check34 days agoChange DetectedAdded a government-operating-status notice and new version v3.2.0; removed old version v3.1.0.SummaryDifference3%

- Check41 days agoChange Detected- Updated version from v3.0.2 to v3.1.0. - No other content changes detected.SummaryDifference0.1%

- Check48 days agoChange DetectedThe page adds a detailed, up-to-date results-reporting section (dates, definitions, and endpoints) for safety, efficacy, and pharmacokinetics, while removing several older, broader metrics. This signals moved-forward, finalized trial results emphasis.SummaryDifference75%

- Check55 days agoChange DetectedUpdated page revision from v3.0.1 to v3.0.2 and removed the 'Back to Top' link.SummaryDifference0.3%

- Check63 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes to core content or other important elements.SummaryDifference0.3%

Stay in the know with updates to Immunotherapy Combination in Solid Cancers Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Immunotherapy Combination in Solid Cancers Clinical Trial page.